Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

ESI Special Topic of:
"Apoptosis," Published May 2002

•> Search Special Topics
Apoptosis Menu

Apoptosis

An INTERVIEW with Dr. Douglas R. Green

ESI Special Topics, July 2000
Citing URL - http://www.esi-topics.com/apoptosis/interviews/DrDouglasRGreen.html

In this interview, Dr. Douglas R. Green talks with Special Topics about his highly cited work in apoptosis research. In our analysis of this field over the past decade, Dr. Green ranks within the top 5 scientists, with 113 papers cited a total of 14,995 times; two of these papers are among the 25 most-cited. Dr. Green’s work can be found in several fields in ISI Essential Science Indicators Web product, including Clinical Medicine, Molecular Biology & Genetics, Biology & Biochemistry, and Immunology. Dr. Green is the head of the Division of Cellular Immunology at the La Jolla Institute for Allergy and Immunology and Adjunct Professor of Biology at the University of California, San Diego.

ST:  What prior research or whose prior work helped to start you on your way?

I came from a background in immune regulation and a long interest in the inhibition of immune responses, which I began together with Richard Gershon, Charlie Janeway, and others at Yale. In the mid-to-late-1980s this led me to think about the phenomenon of negative selection and how it might come about. I had just read a book on developmental biology that indicated that practically nothing was known about programmed cell death in development, and the phenomenon of negative selection (in which antigen-stimulated developing T cells disappear from the thymus) seemed a good system for study. It was!

ST:  What would you rate as your most difficult or trying professional moment?

Honestly? Writing grants (and having them reviewed) is universally difficult and trying—horrendously so. But there is no doubt that it is through this process that ideas are organized, refined, and communicated, and I know of no fairer way to apportion research funds. I've been extraordinarily fortunate to have worked in countries (Canada and the U.S.) where scientific research is so valued. Nevertheless, when applying for support I can clearly see all the things that might or will go wrong with the work, and the complexity of the problems can be nearly overwhelming. Difficult or trying indeed.

ST:  Which of your professional achievements brings you the most satisfaction?

Each time an idea is successfully tested experimentally, each time an unexpected result turns out to be reproducible—these are enormously satisfying. When one of the terrific people in my lab manages to do this, that just about makes my week. Sometimes my year. I think this is true for most scientists, isn't it?

ST:  What impact might your work and research advances in your field have on the general public?

Apoptosis affects every cell type and organ system; it is an important part of normal development and homeostasis, and the major protection from spontaneous cell transformation leading to cancer. It is also the basis for degenerative diseases and many types of tissue damage. An in-depth understanding of apoptosis and how it can be controlled has wide-ranging implications for health and disease.

ST:  Did you expect your work to become highly cited, or is this surprising to you?

I am enormously enthusiastic about the field of apoptosis, and our work represents only a very small contribution to this extraordinary area of study. I didn't know that our work was highly cited, but I'm very pleased since I am very proud of the wonderful people I have had a chance to work with.

ST:  What lessons would you draw from your work to pass on to the next generation of researchers?

I always say that one should never get into science to become famous, get rich, or attain power—this will almost inevitably lead to terrible disappointment. Hopefully one does science because it’s great fun—yes, there are MANY things we do that are NOT fun, but overall, science is a blast. Remember why you got into it in the first place, and hold that as a part of why you continue to do it, and this will bring satisfaction and success. Enlist all your energy, creativity, and enthusiasm for your work (who, in the world, should be more interested in your work than you are?).

The most important lesson? Read. Read a lot. Not only in your field. Ideas come from mixing the observations and ideas of others and integrating them with your own.

ST:  If you had the power to make a single, sweeping change in the way that scientific research is conducted and presented, what would it be?

I have to admit that I pretty much LIKE the way science is conducted and presented. I believe in process, and I think that the way we do science today is a result of an interactive process that constantly changes on its own. Many of the changes we seek to make in a unilateral way negate this concept (funding by political lobbying, elimination of professionally edited journals, etc), which would be a mistake.

Science is a system of faith—when we read a paper we have to believe that the work was actually done as stated, and that the results were examined critically. Scientific meetings are one way that we can interact in order to form these opinions about each other that are so critical to this faith system. We should not deceive ourselves that this is not important, or that they can be replaced by simply webcasting lectures.

Similarly, the hard work that goes into the management and supervision of journals by dedicated scientists provides an invaluable service to the community, allowing us to begin to sort through the volume of information that can be overwhelming (especially when we try to read outside our fields of expertise). While the free availability of literature (even of older literature) has proven to be invaluable, I wouldn't want to see an undermining of the service that these scientists provide to us.

In short, the system sorts itself out quite nicely—if I had the power to make a sweeping change, I think I'd opt not to use it.

ST:  Would you like to leave any other comments about your work or share a personal side of yourself?

While I'm not entirely sure why I am being listed here, I appreciate it. Most of all, it gives me a chance to thank two people who hugely influenced and continue to influence my life. My parents, Warren and Lila Green. As a child I grew up taking it for granted that families go camping, take nature hikes, transplant wildflowers, learn the birds and trees, and investigate the natural world in every way. They encouraged me to explore my interest in science, and supported my strange decision to do it professionally. Both my sister and I are now scientists (Susan Trivelpiece, my sister, is a wildlife biologist who studies penguins in the Antarctic; I am enormously proud of her). I think we owe our scientific careers in great part to these two amazing people. So thank you for giving me the opportunity to say "thanks" in public.End

Douglas R. Green
La Jolla Institute for Allergy and Immunology
La Jolla, California, USA

ESI Special Topics, July 2000
Citing URL - http://www.esi-topics.com/apoptosis/interviews/DrDouglasRGreen.html

ESI Special Topic of:
"Apoptosis," Published May 2002

•> Search Special Topics
Apoptosis Menu || All Topics Menu ||
Interview Index
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.